AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965
Toby A Dite, Christopher G Langendorf, Ashfaqul Hoque, Sandra Galic, Richard J Rebello, Ashley J Ovens, Lisa M Lindqvist, Kevin RW Ngoei, Naomi XY Ling, Luc Furic, Bruce E Kemp, John W Scott, Jonathan S Oakhill
Journal of Biological Chemistry | AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC | Published : 2018
Awarded by Jack Brockhoff foundation
Awarded by Department of Health and Human Services acting through the Victorian Cancer Agency
This work was supported by grants from the Australian Research Council (ARC), Cancer Australia, the National Health and Medical Research Council (NHMRC), and the Jack Brockhoff foundation (Grant JBF-4206, 2016). The authors declare that they have no conflicts of interest with the contents of this article.An NHMRC Early Career Research Fellow. Supported in part by the Victorian Government's Operational Infrastructure Support Program.Supported by the Department of Health and Human Services acting through the Victorian Cancer Agency (MCRF16007).